{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","spread":"13.3","value":"67.8"},{"groupId":"OG001","spread":"13.6","value":"66.9"},{"groupId":"OG002","spread":"11.2","value":"0.9"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"385"},{"groupId":"OG001","value":"385"},{"groupId":"OG002","value":"385"}],"units":"Participants"}],"description":"Patient vital signs were measured before and after 68Ga-PSMA-11 injections and absolute mean change was calculated.","dispersionType":"Standard Deviation","groups":[{"description":"All patients were assessed for safety measures that included Heart Rate before infusion","id":"OG000","title":"Pre-Infusion Heart Rate"},{"description":"All patients were assessed for safety measures that included Heart Rate after infusion","id":"OG001","title":"Post-Infusion Heart Rate"},{"description":"All subjects had the absolute mean in heart rate calculated to assess for safety","id":"OG002","title":"Absolute Change in Heart Rate"}],"paramType":"MEAN","reportingStatus":"POSTED","timeFrame":"1 day","title":"Safety Assessment - Heart Rate","type":"SECONDARY","unitOfMeasure":"beats per minute"}